市場調査レポート

商品コード

1452837

湿潤創傷被覆材の世界市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別 - 産業予測（2024～2031年）

Global Moist Wound Dressings Market Size, Share, Growth Analysis, By Product(Foams, Hydrocolloids), By Application(Pressure Ulcers, Diabetic Ulcers), By End-user(Hospitals, Homecare) - Industry Forecast 2024-2031

出版日: 2024年03月10日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の湿潤創傷被覆材の市場規模は、2022年に43億1,000万米ドルとなり、2023年の45億3,000万米ドルから、2031年までには68億米ドルに成長する見通しで、予測期間（2024～2031年）のCAGRは5.2%です。

湿潤創傷被覆材の世界市場は、高度な創傷ケアへの注目の高まりと、糖尿病性潰瘍や褥瘡などの慢性創傷の急増に後押しされ、力強い成長を示しています。湿潤創傷被覆材は最適な治癒環境を促進し、感染を予防し、創傷の回復を早めるため、ヘルスケア専門家の間で採用が進んでいます。これらの被覆材には、保湿性の向上、痛みの軽減、患者の快適性の向上といった利点があります。さらに、革新的な材料や技術によって湿潤創傷被覆材の効果を高めるため、研究開発が続けられています。高齢化社会の拡大とヘルスケアインフラの世界の進歩に伴い、効率的な創傷管理ソリューションへの需要が当面の市場成長を牽引すると予想されます。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

湿潤創傷被覆材の世界市場：製品別

市場概要
フォーム
ハイドロコロイド
半透過膜
ヒドロゲル
アルギン酸塩
ハイドロファイバー・コラーゲン

湿潤創傷被覆材の世界市場：用途別

市場概要
褥瘡
糖尿病性潰瘍
火傷
手術創傷
外傷性創傷
その他

湿潤創傷被覆材の世界市場：エンドユーザー別

市場概要
病院
ホームケア
クリニック
その他

湿潤創傷被覆材の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

3M Healthcare（US）
Coloplast A/S（Denmark）
Medline Industries, Inc.（US）
Cardinal Health, Inc.（US）
B. Braun Melsungen AG（Germany）
Smith & Nephew PLC（UK）
ConvaTec Group PLC（UK）
Derma Sciences, Inc.（US）
Systagenix Wound Management Ltd（UK）
Molnlycke Health Care AB（Sweden）
Johnson & Johnson（US）
Hollister Incorporated（US）
Ethicon, Inc.（US）
Acelity L.P. Inc.（US）
Advancis Medical（UK）
Coloplast Corporation（US）
Medtronic plc（Ireland）
Molnlycke Health Care（US）
Urgo Medical（France）
Medline Industries Ltd.（UK）
In May 2023, Kane Biotech Inc.（referred to as Kane Biotech）announced that it had gotten 510（k）freedom from the U.S. Food, Drug Administration（FDA）for its coactiv+（TM）Antimicrobial Injury Gel. This clearance covers the management of ulcers（counting diabetic foot and leg ulcers and pressure ulcers）, first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds,, and careful entry points for grown-up populaces.
In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve（TM）Antimicrobial Injury Gel（previously known as coactiv+（TM）Antimicrobial Injury Gel）.

Product Code: SQMIG35D2162

Global Moist Wound Dressings market size was valued at USD 4.31 billion in 2022 and is poised to grow from USD 4.53 billion in 2023 to USD 6.80 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).

The global market for moist wound dressings demonstrates robust growth, propelled by the rising focus on advanced wound care and the escalating prevalence of chronic wounds like diabetic ulcers and pressure sores. Healthcare professionals are increasingly embracing moist wound dressings due to their capacity to foster an optimal healing environment, prevent infections, and expedite wound recovery. These dressings offer benefits such as enhanced moisture retention, reduced pain, and improved patient comfort. Furthermore, ongoing research and development endeavors are dedicated to enhancing the effectiveness of moist wound dressings through innovative materials and technologies. With the aging population expanding and healthcare infrastructure advancing globally, the demand for efficient wound management solutions is anticipated to drive the market's growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Moist Wound Dressings Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Moist Wound Dressings Market Segmental Analysis

The global moist wound dressings market is segmented on the basis of Product, Application, End user, and region. By Product, the market is segmented into Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Other Dressings. By Application, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical and Traumatic Wounds, Burns, Others. By End user, the market is segmented into Hospitals, Clinics, Home Healthcare. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Moist Wound Dressings Market

A significant factor driving the global moist wound dressings market is the ongoing progress in wound care technologies and materials. Developments in dressing materials, including hydrocolloids, hydrogels, and foam dressings, have resulted in more efficient and adaptable products that foster optimal wound healing environments. Moreover, the incorporation of antimicrobial agents and the creation of smart dressings capable of monitoring wound conditions are enhancing the therapeutic properties of moist wound dressings. These advancements are leading to increased adoption by healthcare professionals and patients, thereby stimulating market growth.

Restraints in the Global Moist Wound Dressings Market

A significant constraint in the global moist wound dressings market is the stringent regulatory landscape governing medical devices and healthcare products. Adhering to diverse regulatory requirements and securing necessary approvals can be a laborious and expensive endeavor for manufacturers. Moreover, evolving regulations and differing standards across various regions can present hurdles for market expansion and product advancement. Negotiating these regulatory obstacles can slow down the pace of innovation and market entry for moist wound dressing products.

Market Trends of the Global Moist Wound Dressings Market

A significant trend in the global moist wound dressings market is the growing focus on integrating bioactive ingredients into these dressings. Manufacturers are exploring the inclusion of substances such as silver, honey, and growth factors to enhance the therapeutic properties of the dressings. These bioactive additives hold promise in expediting wound healing, lowering infection rates, and enhancing overall patient outcomes. As healthcare providers and patients increasingly seek more efficient and comprehensive wound care solutions, moist dressings with bioactive elements are gaining momentum, signaling a noteworthy transition towards advanced and tailored wound management approaches.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Moist Wound Dressings Market by Product

Market Overview
Foams
Hydrocolloids
Semi-Permeable Films
Hydrogels
Alginates
Hydro Fibres and Collagens

Global Moist Wound Dressings Market by Application

Market Overview
Pressure Ulcers
Diabetic Ulcers
Burn Wounds
Surgical Wounds
Traumatic Wounds
and Others

Global Moist Wound Dressings Market by End-user

Market Overview
Hospitals
Homecare
Clinics
and Others

Global Moist Wound Dressings Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

3M Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Systagenix Wound Management Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hollister Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acelity L.P. Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancis Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Urgo Medical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
In May 2023, Kane Biotech Inc. (referred to as Kane Biotech) announced that it had gotten 510(k) freedom from the U.S. Food and Drug Administration (FDA) for its coactiv+(TM) Antimicrobial Injury Gel. This clearance covers the management of ulcers (counting diabetic foot and leg ulcers and pressure ulcers), first and severe-degree burns, fractional and full-thickness wounds, enormous surface region wounds, and careful entry points for grown-up populaces.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
In November 2023, Kane Biotech Inc., in collaboration with ProgenaCare Global LLP, disclosed the rebranded revyve(TM) Antimicrobial Injury Gel (previously known as coactiv+(TM) Antimicrobial Injury Gel).
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments